STOCK TITAN

[Form 4] Ibotta, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Form 4 – AMREP Corp. (AXR)

On 07/17/2025, CFO & VP Adrienne M. Uleau was granted 2,100 shares of AMREP common stock at a price of $0 under the 2016 Equity Compensation Plan, indicating time-based restricted stock rather than an open-market purchase. After the grant, her direct beneficial ownership rose to 8,324 shares.

The award vests in three equal tranches of 700 shares on 17 Jul 2026, 17 Jul 2027 and 17 Jul 2028, contingent on Ms. Uleau’s continued employment. No derivative securities or sales were reported.

The filing slightly increases insider ownership and aligns management incentives, but the share amount is immaterial relative to AMREP’s total shares outstanding, suggesting minimal dilution and limited market impact.

Modulo 4 – AMREP Corp. (AXR)

Il 17/07/2025, la CFO e VP Adrienne M. Uleau ha ricevuto in concessione 2.100 azioni ordinarie AMREP al prezzo di $0 nell’ambito del Piano di Compensazione Azionaria 2016, segnalando azioni vincolate basate sul tempo e non un acquisto sul mercato aperto. Dopo la concessione, la sua proprietà diretta effettiva è aumentata a 8.324 azioni.

Il premio si matura in tre tranche uguali di 700 azioni il 17 luglio 2026, 17 luglio 2027 e 17 luglio 2028, subordinato alla continuazione dell’impiego della signora Uleau. Non sono stati riportati titoli derivati né vendite.

La comunicazione aumenta leggermente la proprietà interna e allinea gli incentivi della direzione, ma la quantità di azioni è irrilevante rispetto al totale delle azioni in circolazione di AMREP, suggerendo una diluizione minima e un impatto limitato sul mercato.

Formulario 4 – AMREP Corp. (AXR)

El 17/07/2025, la CFO y VP Adrienne M. Uleau recibió la concesión de 2.100 acciones ordinarias de AMREP a un precio de $0 bajo el Plan de Compensación en Acciones de 2016, indicando acciones restringidas basadas en tiempo en lugar de una compra en el mercado abierto. Tras la concesión, su propiedad directa beneficiaria aumentó a 8.324 acciones.

El premio se consolida en tres tramos iguales de 700 acciones el 17 de julio de 2026, 2027 y 2028, condicionado a la continuidad laboral de la Sra. Uleau. No se reportaron valores derivados ni ventas.

La presentación incrementa ligeramente la propiedad interna y alinea los incentivos de la gerencia, pero la cantidad de acciones es insignificante en relación con el total de acciones en circulación de AMREP, lo que sugiere una dilución mínima y un impacto limitado en el mercado.

양식 4 – AMREP Corp. (AXR)

2025년 7월 17일, CFO 겸 부사장 Adrienne M. Uleau가 2016년 주식 보상 계획에 따라 AMREP 보통주 2,100주를 $0 가격으로 부여받았으며, 이는 공개 시장 구매가 아닌 시간 기반 제한 주식임을 나타냅니다. 부여 후 그녀의 직접 실질 소유권8,324주로 증가했습니다.

이 수여는 2026년 7월 17일, 2027년 7월 17일, 2028년 7월 17일에 각각 700주씩 세 번에 걸쳐 베스팅되며, Uleau 씨가 계속 근무하는 조건입니다. 파생 증권이나 매도는 보고되지 않았습니다.

이번 신고는 내부자 소유권을 약간 증가시키고 경영진의 인센티브를 조정하지만, 주식 수는 AMREP의 총 발행 주식 수에 비해 미미하여 희석 효과가 거의 없고 시장 영향도 제한적임을 시사합니다.

Formulaire 4 – AMREP Corp. (AXR)

Le 17/07/2025, la CFO et VP Adrienne M. Uleau s’est vue attribuer 2 100 actions ordinaires AMREP à un prix de 0 $ dans le cadre du Plan de Compensation en Actions 2016, indiquant des actions restreintes basées sur le temps plutôt qu’un achat sur le marché libre. Après cette attribution, sa possession directe bénéficiaire est montée à 8 324 actions.

La récompense est acquise par trois tranches égales de 700 actions les 17 juillet 2026, 2027 et 2028, sous condition de la poursuite de l’emploi de Mme Uleau. Aucun titre dérivé ni vente n’a été signalé.

Le dépôt augmente légèrement la détention des initiés et aligne les incitations de la direction, mais le nombre d’actions reste négligeable par rapport au total des actions en circulation d’AMREP, suggérant une dilution minimale et un impact limité sur le marché.

Formular 4 – AMREP Corp. (AXR)

Am 17.07.2025 wurde der CFO & VP Adrienne M. Uleau im Rahmen des Aktienvergütungsplans 2016 2.100 Aktien von AMREP-Stammaktien zum Preis von 0 $ gewährt, was auf zeitlich gebundene Restricted Stocks und keinen Kauf am freien Markt hinweist. Nach der Gewährung stieg ihr direktes wirtschaftliches Eigentum auf 8.324 Aktien.

Die Zuteilung wird in drei gleichen Tranchen von jeweils 700 Aktien am 17.07.2026, 17.07.2027 und 17.07.2028 fällig, vorbehaltlich der fortgesetzten Beschäftigung von Frau Uleau. Es wurden keine Derivate oder Verkäufe gemeldet.

Die Meldung erhöht leicht den Insiderbesitz und stimmt die Managementanreize ab, doch die Aktienanzahl ist im Verhältnis zu den insgesamt ausstehenden AMREP-Aktien unerheblich, was auf minimale Verwässerung und begrenzte Marktauswirkungen hindeutet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small restricted-stock grant; marginal ownership rise; largely neutral for valuation.

The 2,100-share grant increases the CFO’s stake to 8,324 shares, enhancing incentive alignment without cash outlay. Because the award represents a negligible percentage of AMREP’s float, dilution risk is de minimis and trading liquidity should be unaffected. From a market perspective, the event is routine compensation disclosure and unlikely to move the stock.

Modulo 4 – AMREP Corp. (AXR)

Il 17/07/2025, la CFO e VP Adrienne M. Uleau ha ricevuto in concessione 2.100 azioni ordinarie AMREP al prezzo di $0 nell’ambito del Piano di Compensazione Azionaria 2016, segnalando azioni vincolate basate sul tempo e non un acquisto sul mercato aperto. Dopo la concessione, la sua proprietà diretta effettiva è aumentata a 8.324 azioni.

Il premio si matura in tre tranche uguali di 700 azioni il 17 luglio 2026, 17 luglio 2027 e 17 luglio 2028, subordinato alla continuazione dell’impiego della signora Uleau. Non sono stati riportati titoli derivati né vendite.

La comunicazione aumenta leggermente la proprietà interna e allinea gli incentivi della direzione, ma la quantità di azioni è irrilevante rispetto al totale delle azioni in circolazione di AMREP, suggerendo una diluizione minima e un impatto limitato sul mercato.

Formulario 4 – AMREP Corp. (AXR)

El 17/07/2025, la CFO y VP Adrienne M. Uleau recibió la concesión de 2.100 acciones ordinarias de AMREP a un precio de $0 bajo el Plan de Compensación en Acciones de 2016, indicando acciones restringidas basadas en tiempo en lugar de una compra en el mercado abierto. Tras la concesión, su propiedad directa beneficiaria aumentó a 8.324 acciones.

El premio se consolida en tres tramos iguales de 700 acciones el 17 de julio de 2026, 2027 y 2028, condicionado a la continuidad laboral de la Sra. Uleau. No se reportaron valores derivados ni ventas.

La presentación incrementa ligeramente la propiedad interna y alinea los incentivos de la gerencia, pero la cantidad de acciones es insignificante en relación con el total de acciones en circulación de AMREP, lo que sugiere una dilución mínima y un impacto limitado en el mercado.

양식 4 – AMREP Corp. (AXR)

2025년 7월 17일, CFO 겸 부사장 Adrienne M. Uleau가 2016년 주식 보상 계획에 따라 AMREP 보통주 2,100주를 $0 가격으로 부여받았으며, 이는 공개 시장 구매가 아닌 시간 기반 제한 주식임을 나타냅니다. 부여 후 그녀의 직접 실질 소유권8,324주로 증가했습니다.

이 수여는 2026년 7월 17일, 2027년 7월 17일, 2028년 7월 17일에 각각 700주씩 세 번에 걸쳐 베스팅되며, Uleau 씨가 계속 근무하는 조건입니다. 파생 증권이나 매도는 보고되지 않았습니다.

이번 신고는 내부자 소유권을 약간 증가시키고 경영진의 인센티브를 조정하지만, 주식 수는 AMREP의 총 발행 주식 수에 비해 미미하여 희석 효과가 거의 없고 시장 영향도 제한적임을 시사합니다.

Formulaire 4 – AMREP Corp. (AXR)

Le 17/07/2025, la CFO et VP Adrienne M. Uleau s’est vue attribuer 2 100 actions ordinaires AMREP à un prix de 0 $ dans le cadre du Plan de Compensation en Actions 2016, indiquant des actions restreintes basées sur le temps plutôt qu’un achat sur le marché libre. Après cette attribution, sa possession directe bénéficiaire est montée à 8 324 actions.

La récompense est acquise par trois tranches égales de 700 actions les 17 juillet 2026, 2027 et 2028, sous condition de la poursuite de l’emploi de Mme Uleau. Aucun titre dérivé ni vente n’a été signalé.

Le dépôt augmente légèrement la détention des initiés et aligne les incitations de la direction, mais le nombre d’actions reste négligeable par rapport au total des actions en circulation d’AMREP, suggérant une dilution minimale et un impact limité sur le marché.

Formular 4 – AMREP Corp. (AXR)

Am 17.07.2025 wurde der CFO & VP Adrienne M. Uleau im Rahmen des Aktienvergütungsplans 2016 2.100 Aktien von AMREP-Stammaktien zum Preis von 0 $ gewährt, was auf zeitlich gebundene Restricted Stocks und keinen Kauf am freien Markt hinweist. Nach der Gewährung stieg ihr direktes wirtschaftliches Eigentum auf 8.324 Aktien.

Die Zuteilung wird in drei gleichen Tranchen von jeweils 700 Aktien am 17.07.2026, 17.07.2027 und 17.07.2028 fällig, vorbehaltlich der fortgesetzten Beschäftigung von Frau Uleau. Es wurden keine Derivate oder Verkäufe gemeldet.

Die Meldung erhöht leicht den Insiderbesitz und stimmt die Managementanreize ab, doch die Aktienanzahl ist im Verhältnis zu den insgesamt ausstehenden AMREP-Aktien unerheblich, was auf minimale Verwässerung und begrenzte Marktauswirkungen hindeutet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Sheppard Valarie L

(Last) (First) (Middle)
C/O IBOTTA, INC.
1801 CALIFORNIA STREET, SUITE 400

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ibotta, Inc. [ IBTA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Interim CFO
3. Date of Earliest Transaction (Month/Day/Year)
07/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/17/2025 F(1) 1,850 D $36.92 34,467(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
2. Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
Remarks:
/s/ David T. Shapiro, by power of attorney 07/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Ibotta

NYSE:IBTA

IBTA Rankings

IBTA Latest News

IBTA Latest SEC Filings

IBTA Stock Data

943.32M
14.30M
54.54%
49.62%
5.4%
Software - Application
Services-advertising
Link
United States
DENVER